Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats

Journal of Trace Elements in Medicine and Biology

Volumn 26, Issue 4, 2012, Pages 255-261

  Liu, Jia Guo ^a   Zhao, Hong Jin ^a   Liu, Yan Juan ^a   Liu, Yong wang ^a   Wang, Xiao Long ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

AFP; Angiogenesis; GGT; Hepatocarcinogenesis; IGF II; NO; PKC ; Selenium enriched malt; Sodium selenite; T NOS; TNF ; VEGF

Indexed keywords

ALPHA FETOPROTEIN; CYTOKINE; DIETHYLNITROSAMINE; GAMMA GLUTAMYLTRANSFERASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C ALPHA; SELENIUM; SODIUM SELENITE; SOMATOMEDIN B; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DECAPITATION; DIET SUPPLEMENTATION; ENZYME BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MALT; MORTALITY; NONHUMAN; NUTRITIONAL VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SELENIUM ENRICHED MALT;

ALPHA-FETOPROTEINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; GAMMA-GLUTAMYLTRANSFERASE; INSULIN-LIKE GROWTH FACTOR II; LIVER; LIVER NEOPLASMS; MALE; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; SODIUM SELENITE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 84868205248     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2012.02.001     Document Type: Article

References (51)

1. Rayman M.P. The importance of selenium to human health. Lancet 2000, 356:233-241.
2. Allan C.B., Lacourciere G.M., Stadtman T.C. Responsiveness of selenoproteins to dietary selenium. Annual Review of Nutrition 1999, 19:1-16.
3. Diplock A.T. Antioxidants and disease prevention. Molecular Aspects of Medicine 1994, 15:293-376.
4. Behne D., Kyriakopoulos A. Mammalian selenium-containing proteins. Annual Review of Nutrition 2001, 21:453-473.
5. Beck M.A., Esworthy R.S., Ho Y.S. Glutathione peroxidase protects mice from viral-induced myocarditis. The Faseb Journal 1998, 12:1143-1149.
6. Popova N.V. Perinatal selenium exposure decreases spontaneous liver tumorogenesis in CBA mice. Cancer Letter 2002, 179(1):39-42.
7. Combs G.F., Clark L.C., Turnbull B.W. An analysis of cancer prevention by selenium. Biofactors 2001, 14:153-159.
8. Raich P.C., Lü J.X., Thompson H.J., Combs G.F. Selenium in cancer prevention: clinical issues and implications. Cancer Investigation 2001, 19(5):540-553.
9. Ip C., Birringer M., Block E., Kotrebai M., Tyson J.F., Uden P.C., et al. Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. Journal of Agricultural and Food Chemistry 2000, 48(6):2062-2070.
10. Davis C.D., Feng Y., Hein D.W., Finley J.W. The chemical form of selenium influences 3,2'-dimethyl-4-aminobiphenyl-DNA adduct formation in rat colon. The Journal of Nutrition 1999, 129(1):63-69.
11. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
12. Folkman J., Klagsbrun M. Angiogenetic factors. Science 1987, 235:442-447.
13. Teicher B.A. Angiogenesis and cancer metastasis: therapeutic approaches. Critical Reviews in Oncology/Hematology 1995, 20:9-39.
14. Mc Carty M.F. The putative therapeutic value of high-dose selenium in proliferative retinopathies may reflect down-regulation of VEGF production by the hypoxic retina. Medical Hypotheses 2005, 64:159-161.
15. Jing J.X., Han C.Z., Zheng S.M. Study on correlation of serum, tumor tissue selenium and SIL-2R, TNF-α. Chinese Journal of Clinical Oncology 2000, 27:565-567.
16. Li X., Liu Y.M., Qi Z.M., Meng J.R., Liu S.X., Li J.X. Effect of Se on Levels of IL-2, IL-6 and TNF-α in murine serum. China Animal Husbandry and Veterinary Medicine 2007, 34:99-101.
17. Zhang H.L., Jiang Y.F., Fu Z.D., Chen W.R. Effect of Se-PSK on NO content in macrophages. Chinese Traditional and Herbal Drugs 2001, 32:820-822.
18. Deng Y., Huang K.X., Xu H.B. Study of the inhibition of selenium on NO-induced cell injury in human umbilical vein endothelial cells and its mechanism. Journal of Huazhong University of Science and Technology 2002, 30:101-104.
19. Liu J.G., Zhao S., Liu H.J., Wang X.L. Effect of selenium-enriched malt on the antioxidative function and γ-GTase activity in the course of acute hepatocarcinogenesis induced by AFB1 in rats. Journal of Nanjing Agricultural University 2005, 28(1):85-89.
20. Zhao H.J. Effect and mechanism of selenium-enriched malt on hepatocarcinogenesis induced by diethylinitrosamine in rats 2005, College of Veterinary Medicine, Nanjing Agricultural University, China, p. 93-110.
21. Liu J.G., Zhao H.J., Liu Y.J., Wang X.L. Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine. Life Sciences 2006, 78(20):2315-2321.
22. Liu J.G. Effect and neuro-endocrine-immunity mechanism of selenium-enriched malt on hepatocarcinogenesis and it's paraneoplastic syndromes induced by diethylnitrosamine in rats 2005, College of Veterinary Medicine, Nanjing Agricultural University, China.
23. Li J.K., Wang X.L. Effect of dietary organic versus inorganic selenium in laying hens on the productivity, selenium distribution in egg and selenium content in blood, liver and kidney. Journal of Trace Elements in Medicine and Biology 2004, 18:65-68.
24. Zhu H. The research of production selenium malt. Journal of Mountain Agricultural Biology 1999, 4:24-27.
25. Xu R., Xiao P. The study on the form of selenium in Se-malt. Science Food Index 1989, 4:7-9.
26. Palmer R.M.J., Moncad S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factors. Nature 1987, 327:524-526.
27. Brereton R.G. SAS (Statistical Analysis System). Chemometrics and Intelligent Laboratory Systems 1986, 1(1):9.
28. Liu Q., Wang W.Q. Hepatocarcinoma 2000, The People's Health Press, Beijing.
29. Kweon S.H., Park K.A., Choi H. Chemopreventive effect of garlic powder diet in diethylnitrosamine-induced rat hepatocarcinogensis. Life sciences 2003, 77:2515-2526.
30. Ozardali I., Bitiren M., Karakilcik A.Z., Zerin M., Aksoy N., Musa D. Effects of selenium on histopathological and enzymatic changes in experimental liver injury of rats. Experimental and Toxicologic Pathology 2004, 56:59-64.
31. Ortman K., Pehrson B. Selenite and selenium yeast as feed supplements for dairy cows. Journal Veterinary Medicine 1997, 4:373-380.
32. Howard E., Ganther Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 1999, 20:1657-1666.
33. Mayhan W.G. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. The American Journal of Physiology 1999, 276:C1148-C1153.
34. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor a critical cytokine in tumor angiogenesis and potential target for diagnosis and therapy. Journal of Clinical Oncology 2002, 20:4368-4380.
35. Sun D.S., Matsune J.C., Fukuiwa O.T., Ushikai M., Kurono Y.C. TNF-α and endotoxin increase hypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion. Auris Nasus Larynx 2005, 32:243-249.
36. Sauter E.R., Nosbit M., Watson J.C., Klein-Szanto A., Litwin S., Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clinical Cancer Research 1999, 5:775-782.
37. Koivunen J., Aaltonen V., Peltonen J. Protein kinase C (PKC) family in cancer progression. Cancer Letters 2006, 235(1):1-10.
38. Jiang Y.J., Davidson L.A., Lupton J.R. Rapid competitive PCR determination of relative gene expression in limiting tissue samples. Clinical Chemistry 1996, 42:2227-2231.
39. Wei Q.P., Deng H.C., Zhao J. A role of sodium selenite in regulatin expression of p38 mitogen-activated protein kinase and vascular endothelial growth factor in rat mesangial cells. Journal of Chongqin medical university 2005, 30(2):191-196.
40. Bae M.H., Lee M.J., Bae S.K., Lee O.H., Lee Y.M., Park B.C., et al. Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity. Cancer Letters 1998, 12:41-46.
41. Lamm G.M., Christofori G. Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells. Cancer Research 1998, 58:801-807.
42. Coste A., Brugel L., Maitre B., Boussat S., Papon J.F., Wingerstmann L. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. European Respiratory Journal 2000, 15:367-372.
43. Hitchon C., Wong K., Ma G., Reed J., Lyttle D., El-Gabalawy H. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis and Rheumatism 2002, 46:2587-2597.
44. Peron J.M., Shurin M.R., Lotze M.T. Cytokine gene therapy of cancer. Gene therapy of cancer 1999, Academic Press, San Diego, CA, USA. E.C. Lattime, S.L. Gerson (Eds.).
45. Scalia R., Booth G., Lefer D.J. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide. The Faseb Journal 1999, 9:1039-1046.
46. Jozkowicz A., Cooke J.P., Guevara I., Huk I., Funovics P., Pachinger O., et al. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovascular Research 2001, 51:773-783.
47. Babei S., Teichert-Kuliszewska K., Zhang Q., Jones N., Dumont D.J., Stewart D.J. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. The American Journal of Pathology 2003, 162:1927-1936.
48. Papapetropoulos A., Garcia-Cardena G., Madri J.A., Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. The Journal of Clinical Investigation 1997, 100:3131-3139.
49. Hood J.D., Meininger C.J., Ziche M., Granger H.J. VEGF upregulates ecNOS message, protein and NO production in human endothelial cells. The American Journal of Physiology 1998, 273:H1054-H1058.
50. Ganther H. Selenium metabolism and mechanisms of cancer prevention. Advance Experimental Medicine Biology 2001, 492:119-130.
51. Shigeyuki S., Takuji T., Karam E.B. Chemoprevention of carcinogenesis by organoselenium compounds. Journal of Health Science 2000, 46(6):422-425.